Neurodevelopmental outcome of infants with birth asphyxia treated with magnesium sulfate
- 16 February 2006
- journal article
- Published by Wiley in Pediatrics International
- Vol. 48 (1) , 70-75
Abstract
A neuroprotective effect of MgSO(4) has been shown in some animal models of perinatal hypoxic-ischemic brain damage. The aim of the present paper was to determine whether postnatal MgSO(4) infusion (250 mg/kg per day i.v. for 3 days, in combination with dopamine) is safe in infants with severe birth asphyxia, and also observe effects on neurodevelopmental outcome at 18 months. Inclusion criteria were clinical history consistent with perinatal asphyxia; gestational age at least 37 weeks; 5 min Apgar score < or =6; failure to initiate spontaneous respiration within 10 min after birth; and symptoms of encephalopathy. On each day MgSO(4) was infused over 1 h in combination with dopamine (5 microg/kg per min). Changes in vital signs, clinical course of encephalopathy, laboratory variables, and adverse events were monitored. Infants were followed for 18 months. Thirty infants were studied. Mean birthweight was 2878 g; mean gestational age, 39.6 weeks, and median 5 min Apgar score, 3. All required endotracheal intubation for resuscitation. Median age at MgSO(4) initiation was 5 h. All infants had moderate or severe hypoxic-ischemic encephalopathy. Mean serum Mg(2+) concentration remained at least 1.3 mmol/L. MgSO(4) caused no change in physiological variables including mean arterial pressure. Two infants died as neonates, while six of 28 survivors had severe neurodevelopmental disability at 18 months; the remaining 22 had no neurodevelopmental disability. Postnatal infusion of MgSO(4) with dopamine caused no change in physiological variables. Deaths and severe sequelae were less frequent than in reported cases with the same grade of hypoxic-ischemic encephalopathy severity, and this treatment may improve neurodevelopmental outcome in infants with severe birth asphyxia.Keywords
This publication has 31 references indexed in Scilit:
- Effects of magnesium sulphate on amplitude‐integrated continuous EEG in asphyxiated term neonatesActa Paediatrica, 2002
- The value of a scoring system for hypoxic ischaemic encephalopathy in predicting neurodevelopmental outcomeActa Paediatrica, 1997
- Acute effects of two different doses of magnesium sulphate in infants with birth asphyxia.Archives of Disease in Childhood - Fetal and Neonatal Edition, 1995
- Birth asphyxia: incidence, clinical course and outcome in a Swedish populationActa Paediatrica, 1995
- PREVENTION BY MAGNESIUM OF EXOTOTOXIC NEURONAL DEATH IN THE DEVELOPING BRAIN: AN ANIMAL MODEL FOR CLINICAL INTERVENTION STUDIESDevelopmental Medicine & Child Neurology, 1995
- Magnesium sulphate as an alternative and safe treatment for severe persistent pulmonary hypertension of the newborn.Archives of Disease in Childhood - Fetal and Neonatal Edition, 1995
- COMPARISON OF TWO METHODS OF PREDICTING OUTCOME IN PERINATAL ASPHYXIAThe Lancet, 1986
- Magnesium gates glutamate-activated channels in mouse central neuronesNature, 1984
- SEVERE NEONATAL ASPHYXIAActa Paediatrica, 1983
- Hypoxic-ischemic encephalopathy in term neonates: Perinatal factors and outcomeThe Journal of Pediatrics, 1981